| AAP | American Academy of Pediatrics |
| AAV | Adeno-associated virus |
| ACA | Affordable Care Act of 2010 |
| ACHDNC | Advisory Committee on Hereditary Diseases in Newborns and Children (HHS) |
| ACMG | American College of Medical Genetics |
| ASO | Antisense Oligonucleotide |
| BIO | Biotinidase deficiency |
| CDC | Centers for Disease Control and Prevention (HHS) |
| cfDNA | Cell-free DNA |
| ClinGen | The Clinical Genome Resource |
| CMV | Cytomegalovirus |
| CLIA | Clinical Laboratory Improvement Amendments |
| CLIAC | Clinical Laboratory Improvement Advisory Committee |
| CLIR | Collaborative Laboratory Integrated Reports |
| CORN | Council of Regional Networks for Genetic Services |
| CRISPR | Clustered regularly interspaced short palindromic repeats |
| CRISPR-Cas 9 | CRISPR-associated protein 9 |
| DMD | Duchenne muscular dystrophy |
| EHR | Electronic health record |
| EPSDT | Early Periodic Screening Diagnosis and Treatment |
| eRNA | Endless Ribonucleic Acid |
| ES | Exome sequencing |
| ExAc | Exome Aggregation Database |
| FDA | Food and Drug Administration (HHS) |
| GAL | Galactosemia |
| GAMT | Guanidinoacetate methyltransferase |
| GAO | Government Accountability Office |
| gnomAD | Genome aggregation database |
| GS | Genome sequencing |
| HDE | Humanitarian Device Exemption |
| HHS | US Department of Health and Human Services |
| HL | Hearing loss |
| HRSA | Health Resources and Services Administration (HHS) |
| HCY | Homocystinuria |
| ICC | Interagency Coordinating Council |
| IEM | Inborn errors of metabolism |
| IND | Investigational new drug |
| IT | Information technology |
| IOM | Institute of Medicine |
| LPDR | Longitudinal pediatric data resource |
| LSD | Lysosomal storage disorder |
| LTFU | Long-term follow-up |
| MSUD | Maple Syrup Urine Disease |
| MIM | Mendelian Inheritance in Man |
| MPS II | mucopolysaccharidosis type II |
| mRNA | Messenger Ribonucleic Acid |
| MS/MS | Tandem mass spectrometry |
| NBS | Newborn screening |
| NBSSLA | Newborn Screening Saves Lives Act of 2008 |
| NBSTRN | Newborn Screening Translational Research Network |
| NCATS | National Center for Advancing Translational Research |
| NHGRI | National Human Genome Research Institute (NIH) |
| NICHD | National Institute of Child Health and Human Development (NIH) |
| NICU | Neonatal intensive care unit |
| NIH | National Institutes of Health (HHS) |
| NORD | National Organization for Rare Diseases |
| NRC/NAS | National Research Council of the National Academy of Sciences |
| NSIGHT | Newborn Sequencing in Genomic Medicine and Public Health |
| NSQAP | Newborn Screening Quality Assurance Program (CDC) |
| ODA | Orphan Drug Act of 1982/83 |
| OMIM | Online Mendelian Inheritance in Man |
| ORD | Office of Rare Diseases (NIH) |
| PKU | Phenylketonuria |
| PPV | Positive predictive value |
| RDCRN | Rare Disease Clinical Research Network |
| RUSP | Recommended Uniform Screening Panel (US.) |
| SCD | Sickle cell disease |
| SCID | Severe combined immunodeficiency |
| SF | Secondary findings |
| siRNA | Small interfering Ribonucleic Acid |
| SMA | Spinal muscular atrophy |
| STFU | Short-term follow-up |
| TREC | T-cell Receptor Excision Circles |
| VUS | Variant of uncertain significance |
| X-ALD | X-linked adrenal leukodystrophy |